| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| tg02 | cyclin-dependent kinase 2 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Anaplastic astrocytoma[MeSHID:D001254] Malignant Neoplasms[MeSHID:D009369] Recurrence (disease attribute)[MeSHID:D012008] Glioblastoma[MeSHID:D005909] |
0.42 | phase 1/2 | unknown |
| tg02 | cyclin-dependent kinase 2 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Anaplastic astrocytoma[MeSHID:D001254] Malignant Neoplasms[MeSHID:D009369] Recurrence (disease attribute)[MeSHID:D012008] Glioblastoma[MeSHID:D005909] |
0.42 | phase 1/2 | inhibitor |
| click here to return to the previous page | ||||||||